AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteML-314 is a brain penetrant nonpeptidic ??-arrestin biased ggonist of the neurotensin NTR1 receptor, which exhibits full agonist behavior against NTR1 (EC50 = 2.0 ??M) in the primary assay and selectivity against NTR2.
More Information Supplier PageML-314 is a brain penetrant nonpeptidic ??-arrestin biased ggonist of the neurotensin NTR1 receptor, which exhibits full agonist behavior against NTR1 (EC50 = 2.0 ??M) in the primary assay and selectivity against NTR2.
More Information Supplier PageMLN0905 is a potent, selective small-molecule PLK1 inhibitor. MLN0905 inhibits cell proliferation in a broad range of human tumor cells including DLBCL cell lines.
More Information Supplier PageMLN0905 is a potent, selective small-molecule PLK1 inhibitor. MLN0905 inhibits cell proliferation in a broad range of human tumor cells including DLBCL cell lines.
More Information Supplier PageMLN0905 is a potent, selective small-molecule PLK1 inhibitor. MLN0905 inhibits cell proliferation in a broad range of human tumor cells including DLBCL cell lines.
More Information Supplier PageMLN0905 is a potent, selective small-molecule PLK1 inhibitor. MLN0905 inhibits cell proliferation in a broad range of human tumor cells including DLBCL cell lines.
More Information Supplier PageMLN0905 is a potent, selective small-molecule PLK1 inhibitor. MLN0905 inhibits cell proliferation in a broad range of human tumor cells including DLBCL cell lines.
More Information Supplier PageMLN2238 is a potent reversible and specific ??5 site of the 20S proteasome inhibitor with an IC50 value of 3.4 nM.
More Information Supplier PageMLN2238 is a potent reversible and specific ??5 site of the 20S proteasome inhibitor with an IC50 value of 3.4 nM.
More Information Supplier PageMLN2238 is a potent reversible and specific ??5 site of the 20S proteasome inhibitor with an IC50 value of 3.4 nM.
More Information Supplier PageMLN2238 is a potent reversible and specific ??5 site of the 20S proteasome inhibitor with an IC50 value of 3.4 nM.
More Information Supplier PageMLN2238 is a potent reversible and specific ??5 site of the 20S proteasome inhibitor with an IC50 value of 3.4 nM.
More Information Supplier PageMLN 2480 is an oral, selective pan-Raf kinase inhibitor in chinical trials.
More Information Supplier PageMLN 2480 is an oral, selective pan-Raf kinase inhibitor in chinical trials.
More Information Supplier PageMLN 2480 is an oral, selective pan-Raf kinase inhibitor in chinical trials.
More Information Supplier PageMLN 2480 is an oral, selective pan-Raf kinase inhibitor in chinical trials.
More Information Supplier PageNAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
More Information Supplier PageNAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
More Information Supplier PageNAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
More Information Supplier PageNAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
More Information Supplier PageNAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
More Information Supplier PageNAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
More Information Supplier PageNAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
More Information Supplier PageNAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
More Information Supplier PageMLN8054 is an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
More Information Supplier PageMLN8054 is an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
More Information Supplier PageMLN8054 is an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
More Information Supplier PageMLN8054 is an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
More Information Supplier PageMLN8054 is an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
More Information Supplier PageMLN8237 (Alisertib) is a selective Aurora kinase A inhibitor with a median IC50 of 61 nM.
More Information Supplier PageMLN8237 (Alisertib) is a selective Aurora kinase A inhibitor with a median IC50 of 61 nM.
More Information Supplier PageMLN8237 (Alisertib) is a selective Aurora kinase A inhibitor with a median IC50 of 61 nM.
More Information Supplier PageMLN8237 (Alisertib) is a selective Aurora kinase A inhibitor with a median IC50 of 61 nM.
More Information Supplier PageMLN8237 (Alisertib) is a selective Aurora kinase A inhibitor with a median IC50 of 61 nM.
More Information Supplier PageMLN9708 is a proteasome inhibitor, which inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome.
More Information Supplier PageMLN9708 is a proteasome inhibitor, which inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome.
More Information Supplier PageMLN9708 is a proteasome inhibitor, which inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome.
More Information Supplier PageMLN9708 is a proteasome inhibitor, which inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome.
More Information Supplier PageMLN9708 is a proteasome inhibitor, which inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome.
More Information Supplier PageMLR 1023 is a selective allosteric activator of Lyn kinase (EC50 = 63 nM)
More Information Supplier PageMLR 1023 is a selective allosteric activator of Lyn kinase (EC50 = 63 nM)
More Information Supplier PageMLR 1023 is a selective allosteric activator of Lyn kinase (EC50 = 63 nM)
More Information Supplier PageMLR 1023 is a selective allosteric activator of Lyn kinase (EC50 = 63 nM)
More Information Supplier Page
